戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ney emerges as an important regulator of the hematopoietic system.
2 l for the development and homeostasis of the hematopoietic system.
3 sis, and leads to the formation of the adult hematopoietic system.
4 ol of stem and progenitor cells in the fetal hematopoietic system.
5 unodeficient mice reconstituted with a human hematopoietic system.
6 disease that disrupts normal function of the hematopoietic system.
7 tor cells of the liver, pyloric stomach, and hematopoietic system.
8  their HSPCs displayed attributes of an aged hematopoietic system.
9 at miR-142 is broadly expressed in the adult hematopoietic system.
10 re repopulate large parts of the recipient's hematopoietic system.
11  generate the lineal precursors of the adult hematopoietic system.
12 erful oncogene in the mammary epithelium and hematopoietic system.
13  acts independently from menin (Men1) in the hematopoietic system.
14 bryo is crucial for development of the adult hematopoietic system.
15  HSCs may underlie many features of the aged hematopoietic system.
16 with support of myeloid lineage cells in the hematopoietic system.
17 ograms and direct cell fate decisions in the hematopoietic system.
18 interactions between mammary cancers and the hematopoietic system.
19 e datasets in high-resolution mapping of the hematopoietic system.
20 inel of cellular stress in the liver and the hematopoietic system.
21 hemogenic endothelium to establish the adult hematopoietic system.
22 we generated mice lacking caspase-9 in their hematopoietic system.
23 e-has been previously developed to study the hematopoietic system.
24 mi1(-/-) mice reconstituted with a wild-type hematopoietic system.
25 odel that acutely deletes Grp78 in the adult hematopoietic system.
26  model with conditional TRF1 deletion in the hematopoietic system.
27 f controls the homeostasis of the Drosophila hematopoietic system.
28 nockout mouse model of GRP78 and PTEN in the hematopoietic system.
29  cellular depletion can reverse aging in the hematopoietic system.
30 esis and a primary target of miR-125b in the hematopoietic system.
31 g developmental defects and breakdown of the hematopoietic system.
32 the mouse and affects the composition of the hematopoietic system.
33 ent that is extensively expressed within the hematopoietic system.
34 escence and expansion/differentiation of the hematopoietic system.
35 significantly to p53-mediated effects on the hematopoietic system.
36 ing the essential autophagy gene Atg7 in the hematopoietic system.
37 an adaptor protein expressed in cells of the hematopoietic system.
38  (HSCs) with functional consequences for the hematopoietic system.
39 l of HSCs to sustain the highly regenerative hematopoietic system.
40 t of phagocytes are central functions of the hematopoietic system.
41 rotein selective functions that modulate the hematopoietic system.
42 d carcinogen, especially in reference to the hematopoietic system.
43 unctional defects of individual cells of the hematopoietic system.
44 led the activation of all 3 integrins in the hematopoietic system.
45 deleted FoxO1, FoxO3, and FoxO4 in the adult hematopoietic system.
46 l role for the development of the definitive hematopoietic system.
47 er as well as genetic diseases affecting the hematopoietic system.
48  antigen and other receptors in cells of the hematopoietic system.
49 natally and show profound alterations in the hematopoietic system.
50 aining multiple organ systems, including the hematopoietic system.
51 is and after perturbations of the endogenous hematopoietic system.
52 lly significant consequences of aging of the hematopoietic system.
53 nta in establishing the mammalian definitive hematopoietic system.
54 ells generally requires ablation of the host hematopoietic system.
55 h most cytokines acting in the immune and/or hematopoietic system.
56 of cell differentiation and apoptosis in the hematopoietic system.
57 gene expression to modulate cell fate in the hematopoietic system.
58 nt HSCs were also unable to reconstitute the hematopoietic system.
59 rstanding of the evolution of the vertebrate hematopoietic system.
60 rsed in Kras(G12D) mice lacking NLRP3 in the hematopoietic system.
61 ult THS exposure had profound effects on the hematopoietic system.
62 d challenges for genetic manipulation of the hematopoietic system.
63 e but experienced equivalent collapse of the hematopoietic system.
64 phoid-specific expression pattern within the hematopoietic system.
65 lular ubH2A level and gene expression in the hematopoietic system.
66 porting myeloid amplification to rebuild the hematopoietic system.
67 the development of several cell types in the hematopoietic system.
68 nesis specifically in the context of an aged hematopoietic system.
69 ariety of phenotypes within the skeletal and hematopoietic systems.
70 d the clonal collapse of both young and aged hematopoietic systems.
71 lar disease include the immune, nervous, and hematopoietic systems.
72 ns caused hyperproliferation in lymphoid and hematopoietic systems.
73             When this process happens in the hematopoietic system, a substantial proportion of circul
74 ettings, such as stimulating recovery of the hematopoietic system after bone marrow transplantation.
75 healthy donor HSPC not only reconstitute the hematopoietic system after transplantation, but also sup
76  stem cells (HSCs) generate all cells of the hematopoietic system, age-associated changes in HSCs may
77                                 In the human hematopoietic system, aging is associated with decreased
78               As with most tissues, the aged hematopoietic system also exhibits a reduced capacity to
79 uction contributes to homeostasis within the hematopoietic system and appropriate responsiveness to i
80 eloid malignancies often arise from an aging hematopoietic system and are currently incurable due to
81 s (HSCs) are the most primitive cells in the hematopoietic system and are under tight regulation for
82 ling of cancer cells both by stimulating the hematopoietic system and by enhancing CD8(+)-dependent t
83 er, PHD2-deficient HSCs replenish the entire hematopoietic system and display an enhanced self-renewa
84 ates Hox gene expression in the adult murine hematopoietic system and dysregulates Hox genes that are
85 sent study, specific deletion of PIT1 in the hematopoietic system and fetal liver transplantation exp
86 we specifically deleted the PDK1 gene in the hematopoietic system and found that PDK1-deficient HSCs
87 scription factor Myb plays a key role in the hematopoietic system and has been implicated in the deve
88 ce of Fbw7-dependent cyclin E control to the hematopoietic system and highlight CIN as a characterist
89 over 1,500 single cells throughout the mouse hematopoietic system and illustrate its utility for reve
90  acceleration of tumor formation both in the hematopoietic system and in sarcomas.
91 ts into the cell-cell cross talk between the hematopoietic system and its microenvironment in the bon
92 erized by the accumulation of B cells in the hematopoietic system and lymphoid tissues.
93 en limited to only a few tissues, mainly the hematopoietic system and mammary gland.
94 lly ablated geminin in the developing murine hematopoietic system and observed profound defects in th
95 ulation of HSCs maintains homeostasis of the hematopoietic system and participates in innate immune r
96 ls (HSCs) lie at the foundation of the adult hematopoietic system and provide an organism throughout
97 ch Scl functions in the establishment of the hematopoietic system and provide evidence that its prima
98 mitigated TBI-induced premature aging of the hematopoietic system and rejuvenated the aged HSCs and M
99 generated a mouse model lacking Hmgb1 in the hematopoietic system and studied the response to acute s
100 ssential for the functional integrity of the hematopoietic system and that its mutations likely contr
101 he complexity of the embryonic origin of the hematopoietic system and the developmental migration of
102 evere side effects that primarily affect the hematopoietic system and the epithelium of the gastroint
103 y described functional interplay between the hematopoietic system and the SNS extends to the earliest
104 s a disease of the vascular endothelium; the hematopoietic system and the vascular endothelium share
105  applied the technology to dissect the human hematopoietic system and to characterize heterogeneous r
106  genes uniquely expressed in HSCs within the hematopoietic system and to develop a reporter strain th
107 , in which Meg3 was deleted in the embryonic hematopoietic system and unexpectedly this did neither g
108  transcriptional control of Elf-4 within the hematopoietic system and, thus, integrate Elf-4 into the
109 udy identifies a link between the neural and hematopoietic systems and opens up the possibility of ma
110 lungs or a prenatally stress-exposed immune (hematopoietic) system and induced allergic asthma via ov
111 it in the maternal brain, rather than in the hematopoietic system, and during gestation was responsib
112                     TEL2 is expressed in the hematopoietic system, and its expression is up-regulated
113 phasis on GATA-1 and GATA-2 functions in the hematopoietic system, and new links between GATA-2 dysre
114 cytes, representing the highly proliferative hematopoietic system, and skeletal muscle, a minimally p
115 n revealed fog1 expression in the heart, the hematopoietic system, and the brain, while fog2a and fog
116 sues, such as the intestinal epithelium, the hematopoietic system, and the male germline.
117              Chronic viral infections of the hematopoietic system are associated with bone marrow dys
118 ts treated for proliferative diseases of the hematopoietic system are characterised by a severe, prog
119 of Nf1 (Nf1(+/-)) and c-kit signaling in the hematopoietic system as required and sufficient for tumo
120  roles in the development and biology of the hematopoietic system, as evidenced by mouse and human ge
121 ong stem cells from different regions of the hematopoietic system at the same time during development
122 mited to the differentiated monocytes in the hematopoietic system both in human and mouse, the identi
123  patients with malignancies of the kidney or hematopoietic system but are often accompanied by severe
124 lycans (HSPGs), is expressed by cells of the hematopoietic system but its role in leukocyte biology i
125 s selectively rescued in the endothelial and hematopoietic systems but not in the skeleton.
126 cacious for multiple genetic diseases of the hematopoietic system, but roughly half of clinical gene
127 facilitates postinjury recovery of the mouse hematopoietic system by promoting proliferation and faci
128 nockdown of all A1 isoforms expressed in the hematopoietic system by RNA interference.
129 titutive or reversible ablation of A1 in the hematopoietic system by RNA interference.
130                  Continuous challenge of the hematopoietic system by serial transplantation provoked
131 em cell fate decisions in the blood-forming (hematopoietic) system by providing a simple and broadly
132 ed both in the (micro)environment and in the hematopoietic system can accelerate thymic involution; h
133  adult angiogenic responses suggest that the hematopoietic system can be a source of endothelial cell
134 hat various tissues, especially parts of the hematopoietic system, can be rejuvenated.
135 aster regulatory transcription factor in the hematopoietic system, can result in a differentiation bl
136  induced by CpG in mice with a Stat3-ablated hematopoietic system cause potent antitumor effects, lea
137                             RHAU deletion in hematopoietic system caused hemolytic anemia and differe
138 ere, we show that a deficiency of A20 in the hematopoietic system causes anemia, lymphopenia, and pos
139                                   Within the hematopoietic system, CD85j is expressed with cell-speci
140 ct its genomic and functional integrity, the hematopoietic system critically depends on the combined
141                                          The hematopoietic system declines with age, resulting in dec
142                                          The hematopoietic system declines with age.
143 IN can function as a tumor suppressor in the hematopoietic system: deletion of Atmin under the contro
144                 Lineage specification in the hematopoietic system depends on the expression of lineag
145     Mice expressing active Kras(G12D) in the hematopoietic system developed myeloproliferation and cy
146 nges and downregulation of genes involved in hematopoietic system development and function.
147                                          The hematopoietic system develops during embryogenesis at te
148             Inactivation of Lrp5 and -6 in a hematopoietic system diminished the pool of HSCs, but th
149   Correspondingly, mice lacking Sphk2 in the hematopoietic system display thrombocytopenia.
150 ) mouse model, BMT mice with a reconstituted hematopoietic system displayed increased susceptibility
151 imeric wild-type mice with a CG/NE-deficient hematopoietic system displayed significantly increased l
152 arction (MI), myeloid cells derived from the hematopoietic system drive a sharp increase in systemic
153 ic mice expressing the mutated enzyme in the hematopoietic system driven by a vav gene promoter.
154 icated in the establishment of the primitive hematopoietic system during mouse embryonic development.
155  In mice, specific knockdown of SHIP1 in the hematopoietic system following retroviral delivery of a
156                       Prdm16 deletion in the hematopoietic system following transplantation produced
157                 LTR HSC can reconstitute the hematopoietic system for life, whereas STR HSC can susta
158 he ability of stem cells to reconstitute the hematopoietic system for many decades after the administ
159 athway represents a leading model within the hematopoietic system for the analysis of genetic network
160 ing sufficient H3K9me3 to protect the entire hematopoietic system from changes associated with premat
161 critical factors that govern recovery of the hematopoietic system from stress, such as during antican
162                                   Within the hematopoietic system, Ghr is expressed in a highly HSC-s
163 show that Prdm16 deletion in the adult mouse hematopoietic system has a less severe effect on HSCs, c
164      Together, our results indicate that the hematopoietic system has a remarkable tolerance for majo
165 ectively in the development of the mammalian hematopoietic system has been difficult to ascertain bec
166                       In contrast, after the hematopoietic system has been perturbed by irradiation o
167 me time during development suggests that the hematopoietic system has evolved mechanisms to prevent t
168 a general role for the lipocalin 24p3 in the hematopoietic system has not been tested in vivo.
169      Therefore, strategies to rejuvenate the hematopoietic system have important clinical implication
170 ces in the understanding of the cells of the hematopoietic system have provided a rich basis for impr
171 velopment as well as normal functions of the hematopoietic system, heart, and kidney in adults.
172                                 In the adult hematopoietic system, HH signaling regulates intrathymic
173 such as the skin, gastrointestinal tract and hematopoietic system, homeostasis is dependent on the co
174                 We further characterized the hematopoietic system in individuals with CH as follows:
175  marrow cells prior to reconstitution of the hematopoietic system in lethally irradiated mice.
176 by E2F transcription factors in a BM-derived hematopoietic system in mice, we uncovered a functional
177 econstitution of this genetically engineered hematopoietic system in mice.
178 re, we review recent studies implicating the hematopoietic system in plexiform neurofibroma genesis,
179 s a juxtacrine homeostatic adaptation of the hematopoietic system in stress myelopoiesis.
180 e Vav promoter to express MYC throughout the hematopoietic system in transgenic mice.
181 as warranted a therapeutic potential for the hematopoietic system in treating diseases of the CNS.
182 6 is expressed during the development of the hematopoietic system in vivo and in vitro and that its e
183  and to repopulate a functional multilineage hematopoietic system in vivo.
184                                          The hematopoietic systems in the irradiated recipients were
185              Many age-related changes in the hematopoietic system, in particular the clonal myeloid b
186         Human CMV (HCMV) uses members of the hematopoietic system including neutrophils for dissemina
187 ssing IL1RAP, with no apparent effect on the hematopoietic system, including CD34(+) stem cells.
188 s associated with significant changes in the hematopoietic system, including increased inflammation,
189 S exposure induces persistent changes in the hematopoietic system independent of age at exposure.
190 e that P2Y14 on stem/progenitor cells of the hematopoietic system inhibits cell senescence by monitor
191                          NSG mice with human hematopoietic system injected with the HMGB1 antagonist
192                                       In the hematopoietic system, instead of causing the predicted B
193  of multiple tissues, including those of the hematopoietic system, intestine, muscle, brain, skin and
194                       The development of the hematopoietic system is a dynamic process that is contro
195                       Communication with the hematopoietic system is a vital component of regulating
196                                 Aging of the hematopoietic system is associated with an increased inc
197                                 Aging of the hematopoietic system is associated with myeloid malignan
198            However, the role of Dmtf1 in the hematopoietic system is entirely unknown.
199                        The Drosophila larval hematopoietic system is founded by differentiated hemocy
200  the shared phenotype of self-renewal in the hematopoietic system is linked at the molecular level.
201 on and physiological relevance in the murine hematopoietic system is nevertheless elusive.
202     Although the kinetics of recovery of the hematopoietic system is normal, HSCs in a SPARC-deficien
203 s, but the regulation of this process in the hematopoietic system is poorly understood.
204 the vascular endothelium, in addition to the hematopoietic system, is a major contributor of plasma S
205 cell fraction at the foundation of the adult hematopoietic system, is currently of great interest and
206 lays an important role in the development of hematopoietic system, it is less well understood whether
207 and p21 and to induce MDM2 expression in the hematopoietic system, its downstream targets in TNBC are
208 tion of Lis1 (also known as Pafah1b1) in the hematopoietic system led to a severe bloodless phenotype
209 turation of the various cell lineages of the hematopoietic system, less is known about factors that g
210 h beta-arrestin1 and -2 are expressed in the hematopoietic system, loss of beta-arrestin2 preferentia
211     Aging leads to functional decline of the hematopoietic system, manifested by an increased inciden
212                                          The hematopoietic system matures from the fetal state, chara
213  that age-related changes in HSCs and in the hematopoietic system may not entirely be due to a degene
214 lopment of the cardiovascular, excretory and hematopoietic systems may be more closely related than p
215                                   Within the hematopoietic system, members of the Kruppel-like family
216           Overexpressing Lin28A in the mouse hematopoietic system mimicked the phenotype observed on
217                           The fetal/neonatal hematopoietic system must generate enough blood cells to
218                                       In the hematopoietic system, mutations in IDH1 at arginine (R)
219 aracterized by the presence in the patient's hematopoietic system of a large cell population with a m
220  is their ability to reconstitute the entire hematopoietic system of hemoablated recipients.
221 riments showing that genetic deletion in the hematopoietic system of Janus kinase 2 (JAK2) abrogates
222 ficient LSK cells failed to reconstitute the hematopoietic system of lethally irradiated mice.
223 s were unable to adequately reconstitute the hematopoietic system of lethally irradiated recipients.
224 dressed these questions by investigating the hematopoietic system of mice deficient for Rev1, a core
225                                          The hematopoietic system of mice is established during the e
226                              Analysis of the hematopoietic system of mice with the Apc(min) allele th
227 ifferentiated progeny, which can sustain the hematopoietic system of multiple hosts for a long time.
228 has enabled HSCs to be used to replenish the hematopoietic system of patients after chemotherapy or r
229 the leukemogenic potential of SET-CAN in the hematopoietic system of transgenic mice.
230 NF can be effectively supplied by either the hematopoietic system or the CNS, but the essential TNFR1
231 D88 deletion, predominantly in the liver and hematopoietic system, or were crossed with Akr1b7 Cre tr
232 idence indicates that cells derived from the hematopoietic system participate in angiogenesis.
233 egulate cell fate decisions in the mammalian hematopoietic system, playing crucial roles in stem cell
234                                          The hematopoietic system plays a major role in human health.
235                We show here that, within the hematopoietic system, Prdm16 is expressed very selective
236                                          The hematopoietic system produces new blood cells throughout
237 nown role in defense and debris removal, the hematopoietic system provides critical regenerative driv
238                                          The hematopoietic system provides numerous examples attestin
239                                 In the human hematopoietic system, rare self-renewing multipotent lon
240 e find that inhibition of let-7 in the adult hematopoietic system recapitulates fetal erythroid-domin
241  by donor HSC transplantation enabled stable hematopoietic system reconstitution in recipients with m
242        We find that deletion of SPPL3 in the hematopoietic system reduces numbers of peripheral NK ce
243  angiopoietin-like proteins (Angptls) in the hematopoietic system remain unknown.
244  the mechanistic basis for its impact on the hematopoietic system remains largely unresolved.
245  Widespread inactivation of RB in the murine hematopoietic system resulted in profound myeloprolifera
246                      Dpy30 loss in the adult hematopoietic system results in severe pancytopenia but
247            gp96/grp94 deletion in the murine hematopoietic system results in thrombocytopenia, prolon
248                                          The hematopoietic system's myeloid bias was reflected by inc
249 n highly proliferative organs, including the hematopoietic system, small intestine, and testes.
250 nt a small and heterogeneous fraction of the hematopoietic system, specialized in antigen capture, pr
251  gp96 is also essential for expression of 14 hematopoietic system-specific integrins.
252 l vector HSPC gene therapy generates a human hematopoietic system stably marked at the clonal level b
253                                       In the hematopoietic system, stem cells are characterized by us
254 2b deletion in CD11c-expressing cells of the hematopoietic system survive to adulthood.
255                                          The hematopoietic system sustains regeneration throughout li
256                                       In the hematopoietic system, TGF-beta signaling controls a wide
257 nvolves a tumor/stromal interaction with the hematopoietic system that depends, at the molecular leve
258       Macrophages are versatile cells of the hematopoietic system that display remarkable functional
259 ata annotate developmental mechanisms in the hematopoietic system that enable a decision to be made e
260 n stem cells for tissue homeostasis like the hematopoietic system that forms immune cells, it is beli
261 CSF) is an endogenous peptide hormone of the hematopoietic system that has been shown to be neuroprot
262 CSF) is an endogenous peptide hormone of the hematopoietic system that has entered Phase I/II clinica
263 n powerful new methods for investigating the hematopoietic system that have provided transformative i
264 ically significant conditions arising in the hematopoietic system that include: diminution and decrea
265 ochromic, microcytic anemia intrinsic to the hematopoietic system that is associated with a decreased
266 AML) is an autosomal dominant disease of the hematopoietic system that is caused by heterozygous muta
267 To elucidate the properties of an aged human hematopoietic system that may predispose to age-associat
268                        The only cells of the hematopoietic system that undergo self-renewal for the l
269                                       In the hematopoietic system, the ANS regulates stem cell niche
270                                       In the hematopoietic system, the function of the pathway has be
271 n, differentiation, and proliferation in the hematopoietic system, the intestine, the pancreas, and t
272 nd because they are broadly expressed in the hematopoietic system, their targeting may have unwanted
273 nerating immunocompromised mice with a human hematopoietic system, there are still several shortcomin
274 patterns of stem cell divisions in the human hematopoietic system throughout life.
275 s to assess activity and distribution of the hematopoietic system throughout the whole skeleton of re
276  receptor nuclear translocator (ARNT) in the hematopoietic system to ablate activity of both HIF-1alp
277 nt approach is to engineer the patient's own hematopoietic system to express high levels of the defic
278 homeostasis and highlight the ability of the hematopoietic system to respond to stress without signif
279 ve approach is to engineer the patient's own hematopoietic system to restore glucocerebrosidase expre
280 d with deficits in neurodevelopment and with hematopoietic system toxicity.
281 ding of the accumulation of mutations in the hematopoietic system upon aging.
282 determined that CFU-ECs are derived from the hematopoietic system using progenitor assays, and analys
283 ouse model and deleted Prdm16 in adult mouse hematopoietic system using the IFN-inducible Mx1-Cre Our
284 rs (CMPs) by deletion of Atmin in the entire hematopoietic system using Vav-Cre.
285                                   Beyond the hematopoietic system, Usp3Delta/Delta animals spontaneou
286                             As expected, the hematopoietic system was most affected, with all subject
287 xposure and bone marrow transplantation, the hematopoietic system was successfully reconstituted over
288 nd exhibited GFP expression that, within the hematopoietic system, was restricted predominantly to ly
289                                    Using the hematopoietic system, we analyzed the relative importanc
290                                       In the hematopoietic system, we defined critical decision point
291 further explore its physiologic functions in hematopoietic system, we generated a mouse model with he
292 manull (NSG) mice reconstituted with a human hematopoietic system, we were able to discriminate the r
293 d that the effects of TCDD on the developing hematopoietic system were mediated by direct AHR activat
294             This is particularly true of the hematopoietic system, where demands on host defenses can
295 TL represents TL in the highly proliferative hematopoietic system, whereas TL in skeletal muscle repr
296 erated telomere shortening restricted to the hematopoietic system, which affects the baseline TL of a
297  defects in the development of the zebrafish hematopoietic system, which could be partially rescued b
298                  Thus, Mi-2beta provides the hematopoietic system with immune cell capabilities as we
299 ntly requires depleting a patient's existing hematopoietic system with toxic and non-specific chemoth
300 R/R) mice display altered development of the hematopoietic system without enhanced tumor susceptibili

 
Page Top